Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1976
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study without detailed documentation

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Deviations:
not specified
GLP compliance:
no
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Calcium cyanamide
EC Number:
205-861-8
EC Name:
Calcium cyanamide
Cas Number:
156-62-7
Molecular formula:
CN2.Ca
IUPAC Name:
calcium cyanoazanediide
impurity 1
Chemical structure
Reference substance name:
Calcium oxide
EC Number:
215-138-9
EC Name:
Calcium oxide
Cas Number:
1305-78-8
Molecular formula:
CaO
IUPAC Name:
oxocalcium
impurity 2
Chemical structure
Reference substance name:
Carbon
EC Number:
231-153-3
EC Name:
Carbon
Cas Number:
7440-44-0
Molecular formula:
C
IUPAC Name:
carbon
impurity 3
Chemical structure
Reference substance name:
Calcium carbonate
EC Number:
207-439-9
EC Name:
Calcium carbonate
Cas Number:
471-34-1
Molecular formula:
CH2O3.Ca
IUPAC Name:
calcium carbonate
impurity 4
Reference substance name:
Hematite (Fe2O3)
EC Number:
215-275-4
EC Name:
Hematite (Fe2O3)
Cas Number:
1317-60-8
Molecular formula:
Fe2O3
IUPAC Name:
diiron oxide
impurity 5
Chemical structure
Reference substance name:
Urea
EC Number:
200-315-5
EC Name:
Urea
Cas Number:
57-13-6
Molecular formula:
CH4N2O
IUPAC Name:
urea
impurity 6
Chemical structure
Reference substance name:
Silicon dioxide
EC Number:
231-545-4
EC Name:
Silicon dioxide
Cas Number:
7631-86-9
Molecular formula:
O2Si
IUPAC Name:
dioxosilane
impurity 7
Chemical structure
Reference substance name:
Trisilicon tetranitride
EC Number:
234-796-8
EC Name:
Trisilicon tetranitride
Cas Number:
12033-89-5
Molecular formula:
N4Si3
IUPAC Name:
trisilicon tetranitride
impurity 8
Chemical structure
Reference substance name:
Calcium dihydroxide
EC Number:
215-137-3
EC Name:
Calcium dihydroxide
Cas Number:
1305-62-0
Molecular formula:
CaH2O2
IUPAC Name:
calcium dihydroxide
impurity 9
Chemical structure
Reference substance name:
Aluminium oxide
EC Number:
215-691-6
EC Name:
Aluminium oxide
Cas Number:
1344-28-1
Molecular formula:
Al2O3
IUPAC Name:
aluminium oxide
impurity 10
Chemical structure
Reference substance name:
Cyanoguanidine
EC Number:
207-312-8
EC Name:
Cyanoguanidine
Cas Number:
461-58-5
Molecular formula:
C2H4N4
IUPAC Name:
2-cyanoguanidine
impurity 11
Chemical structure
Reference substance name:
Calcium acetylide
EC Number:
200-848-3
EC Name:
Calcium acetylide
Cas Number:
75-20-7
Molecular formula:
C2Ca
IUPAC Name:
calcium ethynediide
impurity 12
Reference substance name:
unknown
IUPAC Name:
unknown
Test material form:
solid: particulate/powder

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
Young albino rats from the Institute's colony (Wistar derived) males 128 to 240 g and females 128 to 178 g weight were used. They were housed in groups of five in screen-bottomed stainless steel cages, in a well-ventilated room maintained at 25°C. Before dosing the rats were fasted overnight.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
After some preliminary observations the test material was given by gavage as a 10% (w/v) aqueous suspension to groups of five males and five females in single doses of 4.80, 5.76, 8.29 or 9.95 ml per kg body weight.
Doses:
480, 476, 691, 829 and 995 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
After treatment the rats received stock diet and tap water ad libitum. They were observed for signs of intoxication during a 14 days period, after which autopsies were carried out on the survivors. The LD50 was calculated according to the method of Weil (Biometrics 8 (1952) 249-263).
Statistics:
The LD50 was calculated according to the method of Weil (Biometrics 8 (1952) 249-263).

Results and discussion

Preliminary study:
not indicated
Effect levelsopen allclose all
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 765 mg/kg bw
95% CL:
> 0.639 - < 0.845
Remarks on result:
other: calculated for calcium cyanamide 20.5%N
Sex:
male/female
Dose descriptor:
LD0
Effect level:
576 mg/kg bw
Remarks on result:
other: calcium cyanamide technical grade (Kalkstickstoff)
Mortality:
Deaths occurred between 5 and 21 hours after treatment.
Clinical signs:
other: Within a few hours after dosing all rats showed decreased activity and humpback behaviour. Tremors in the legs and loss of conscious were frequently observed. The survivors recovered and looked quite healthy again at the end of the observation period.
Gross pathology:
Macroscopic examination of the survivors did not reveal treatment-related gross alterations.
Other findings:
no other findings

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
From the mortality figures the LD50 of technical calcium cyanamide is calculated to be 765 mg/kg bw with 693 and 845 as the 95% confidence limits, which is equal to 639 mg/kg Calcium cyanamide, technical grade.
Executive summary:

In an acute oral toxicity study, groups of fasted, young Wistar rats (5/sex) were given a single oral dose of calcium cyanamide, technical grade in water by gavage at doses of 480, 576, 691, 829 and 995 mg/kg bw and observed for 14 days.

Within a few hours after dosing all rats showed decreased activity and humpback behaviour. Tremors in the legs and loss of consciousness were frequently observed. Deaths occurred between 5 and 21 hours after treatment. The survivors recovered and looked quite healthy again at the end of the observation period. Macroscopic examination of the survivors did not reveal treatment-related gross alterations.

Oral LD50 = 765 mg/kg bw (693-845 mg/kg bw 95% C.I.), equal to 639 mg/kg Calcium cyanamide, technical grade.